{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:31:07Z","timestamp":1793147467797,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Innovation Project (Ph.D) of Wuxi 9th People\u2019s Hospital Affiliated to Soochow University","award":["YB202101"],"award-info":[{"award-number":["YB202101"]}]},{"name":"Scientific research project of Wuxi science and Technology Bureau","award":["Y20212054"],"award-info":[{"award-number":["Y20212054"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rheumatoid arthritis (RA) is an autoimmune disease characterized by destructive and symmetrical joint diseases and synovitis. This research attempted to explore the mechanisms involving ferroptosis in RA, and find the biological markers by integrated analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Gene expression data (GSE55235 and GSE55457) of synovial tissues from healthy and RA individuals were downloaded. By filtering the differentially expressed genes (DEGs) and intersecting them with the 484 ferroptosis-related genes (FRGs), the overlapping genes were identified. After the enrichment analysis, the machine\u00a0learning-based approaches were introduced to screen the potential biomarkers, which were further validated in other two datasets (GSE77298 and GSE93272) and cell samples. Besides, we also analyze the infiltrating immune cells in RA and their correlation with the biomarkers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>With the criteria, 635 DEGs in RA were included, and 29 of them overlapped in the reported 484 FRGs. The enrichments of the 29 differentially expressed ferroptosis-related genes indicated that they may involve in the FoxO signaling pathway and inherited metabolic disorder. RRM2, validating by the external datasets and western blot, were identified as the biomarker with the high diagnostic value, whose associated immune cells, such as Neutrophils and Macrophages M1, were also further evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We preliminary explored the mechanisms between ferroptosis and RA. These results may help us better comprehend the pathophysiological changes of RA in basic research, and provide new evidences for the clinical transformation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-023-01445-7","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T18:04:01Z","timestamp":1675101841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification of ferroptosis related markers by integrated bioinformatics analysis and In vitro model experiments in rheumatoid arthritis"],"prefix":"10.1186","volume":"16","author":[{"given":"Jinjun","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiubo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"1445_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020905","author":"S Jang","year":"2022","unstructured":"Jang S, Kwon E, Lee J. Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23020905.","journal-title":"Int J Mol Sci"},{"issue":"6937","key":"1445_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"G Firestein","year":"2003","unstructured":"Firestein G. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356\u201361. https:\/\/doi.org\/10.1038\/nature01661.","journal-title":"Nature"},{"key":"1445_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-022-07387-z","author":"A Cordova Sanchez","year":"2022","unstructured":"Cordova Sanchez A, Khokhar F, Olonoff D, Carhart R. Hydroxychloroquine and cardiovascular events in patients with rheumatoid arthritis. Cardiovasc Drugs Ther. 2022. https:\/\/doi.org\/10.1007\/s10557-022-07387-z.","journal-title":"Cardiovasc Drugs Ther"},{"key":"1445_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173806","author":"H Yamakawa","year":"2021","unstructured":"Yamakawa H, Ogura T, Kameda H, Kishaba T, Iwasawa T, Takemura T, et al. Decision-making strategy for the treatment of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10173806.","journal-title":"J Clin Med"},{"key":"1445_CR5","doi-asserted-by":"publisher","first-page":"829677","DOI":"10.3389\/fphar.2022.829677","volume":"13","author":"S Sheng","year":"2022","unstructured":"Sheng S, Wang X, Liu X, Hu X, Shao Y, Wang G, et al. The role of resveratrol on rheumatoid arthritis: From bench to bedside. Front Pharmacol. 2022;13:829677. https:\/\/doi.org\/10.3389\/fphar.2022.829677.","journal-title":"Front Pharmacol"},{"key":"1445_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac085","author":"N Sugimoto","year":"2022","unstructured":"Sugimoto N, Tanaka E, Inoue E, Abe M, Sugano E, Sugitani N, et al. Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: analyses from a 14-year observation of the IORRA cohort. Mod Rheumatol. 2022. https:\/\/doi.org\/10.1093\/mr\/roac085.","journal-title":"Mod Rheumatol"},{"key":"1445_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/1759720x221111613","author":"A Manning-Bennett","year":"2022","unstructured":"Manning-Bennett A, Hopkins A, Sorich M, Proudman S, Foster D, Abuhelwa A, et al. The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis-a pooled analysis of five randomised controlled trials. Therap Adv Musculoskel Dis. 2022. https:\/\/doi.org\/10.1177\/1759720x221111613.","journal-title":"Therap Adv Musculoskel Dis"},{"issue":"10055","key":"1445_CR8","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/s0140-6736(16)30173-8","volume":"388","author":"J Smolen","year":"2016","unstructured":"Smolen J, Aletaha D, McInnes I. Rheumatoid arthritis. Lancet (London, England). 2016;388(10055):2023\u201338. https:\/\/doi.org\/10.1016\/s0140-6736(16)30173-8.","journal-title":"Lancet (London, England)"},{"issue":"7","key":"1445_CR9","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1316\u201322. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204627.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1445_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma S, Lessnick S, Hahn W, Stockwell B. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3(3):285\u201396. https:\/\/doi.org\/10.1016\/s1535-6108(03)00050-3.","journal-title":"Cancer Cell"},{"issue":"5","key":"1445_CR11","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"S Dixon","year":"2012","unstructured":"Dixon S, Lemberg K, Lamprecht M, Skouta R, Zaitsev E, Gleason C, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"key":"1445_CR12","doi-asserted-by":"publisher","first-page":"110108","DOI":"10.1016\/j.biopha.2020.110108","volume":"127","author":"Y Sun","year":"2020","unstructured":"Sun Y, Chen P, Zhai B, Zhang M, Xiang Y, Fang J, et al. The emerging role of ferroptosis in inflammation. Biomed Pharmacother. 2020;127:110108. https:\/\/doi.org\/10.1016\/j.biopha.2020.110108.","journal-title":"Biomed Pharmacother"},{"key":"1445_CR13","doi-asserted-by":"publisher","first-page":"779585","DOI":"10.3389\/fimmu.2022.779585","volume":"13","author":"T Zhao","year":"2022","unstructured":"Zhao T, Yang Q, Xi Y, Xie Z, Shen J, Li Z, et al. Ferroptosis in rheumatoid arthritis: a potential therapeutic strategy. Front Immunol. 2022;13:779585. https:\/\/doi.org\/10.3389\/fimmu.2022.779585.","journal-title":"Front Immunol"},{"issue":"6","key":"1445_CR14","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","volume":"30","author":"B Stockwell","year":"2020","unstructured":"Stockwell B, Jiang X, Gu W. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol. 2020;30(6):478\u201390. https:\/\/doi.org\/10.1016\/j.tcb.2020.02.009.","journal-title":"Trends Cell Biol"},{"issue":"43","key":"1445_CR15","doi-asserted-by":"publisher","first-page":"73529","DOI":"10.18632\/oncotarget.19867","volume":"8","author":"J Zhang","year":"2017","unstructured":"Zhang J, Li C, Zheng Y, Lin Z, Zhang Y, Zhang Z. viaInhibition of angiogenesis by arsenic trioxide TSP-1-TGF-\u03b21-CTGF-VEGF functional module in rheumatoid arthritis. Oncotarget. 2017;8(43):73529\u201346. https:\/\/doi.org\/10.18632\/oncotarget.19867.","journal-title":"Oncotarget"},{"issue":"1","key":"1445_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13568-020-00987-8","volume":"10","author":"J Zhao","year":"2020","unstructured":"Zhao J, Chen X, Cheng K, Shi Q, Peng K. Anserine and glucosamine supplementation attenuates the levels of inflammatory markers in rats with rheumatoid arthritis. AMB Express. 2020;10(1):57. https:\/\/doi.org\/10.1186\/s13568-020-00987-8.","journal-title":"AMB Express"},{"issue":"8917","key":"1445_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/s0140-6736(94)93029-5","volume":"344","author":"F Al-Refaie","year":"1994","unstructured":"Al-Refaie F, Wonke B, Hoffbrand A. Arthropathy in thalassaemia patients receiving deferiprone. Lancet (London, England). 1994;344(8917):262\u20133. https:\/\/doi.org\/10.1016\/s0140-6736(94)93029-5.","journal-title":"Lancet (London, England)."},{"key":"1445_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194690","author":"Z Shi","year":"2022","unstructured":"Shi Z, Zheng J, Liang Q, Liu Y, Yang Y, Wang R, et al. Identification and validation of a novel ferroptotic prognostic genes-based signature of clear cell renal cell carcinoma. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14194690.","journal-title":"Cancers"},{"issue":"2","key":"1445_CR19","doi-asserted-by":"publisher","first-page":"R84","DOI":"10.1186\/ar4526","volume":"16","author":"D Woetzel","year":"2014","unstructured":"Woetzel D, Huber R, Kupfer P, Pohlers D, Pfaff M, Driesch D, et al. Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation. Arthritis Res Ther. 2014;16(2):R84. https:\/\/doi.org\/10.1186\/ar4526.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1445_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1089\/hum.2015.127","volume":"27","author":"M Broeren","year":"2016","unstructured":"Broeren M, de Vries M, Bennink M, Arntz O, Blom A, Koenders M, et al. Disease-regulated gene therapy with anti-inflammatory interleukin-10 under the control of the CXCL10 promoter for the treatment of rheumatoid arthritis. Hum Gene Ther. 2016;27(3):244\u201354. https:\/\/doi.org\/10.1089\/hum.2015.127.","journal-title":"Hum Gene Ther"},{"issue":"1","key":"1445_CR21","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1038\/s41467-018-05044-4","volume":"9","author":"S Tasaki","year":"2018","unstructured":"Tasaki S, Suzuki K, Kassai Y, Takeshita M, Murota A, Kondo Y, et al. Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission. Nat Commun. 2018;9(1):2755. https:\/\/doi.org\/10.1038\/s41467-018-05044-4.","journal-title":"Nat Commun"},{"issue":"3","key":"1445_CR22","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s10528-021-10154-8","volume":"60","author":"C Huang","year":"2022","unstructured":"Huang C, Luo J, Wen X, Li K. Linking diabetes mellitus with Alzheimer\u2019s disease: bioinformatics analysis for the potential pathways and characteristic genes. Biochem Genet. 2022;60(3):1049\u201375. https:\/\/doi.org\/10.1007\/s10528-021-10154-8.","journal-title":"Biochem Genet"},{"issue":"2","key":"1445_CR23","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","volume":"14","author":"J Reimand","year":"2019","unstructured":"Reimand J, Isserlin R, Voisin V, Kucera M, Tannus-Lopes C, Rostamianfar A, et al. Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, cytoscape and EnrichmentMap. Nat Protoc. 2019;14(2):482\u2013517. https:\/\/doi.org\/10.1038\/s41596-018-0103-9.","journal-title":"Nat Protoc"},{"issue":"9","key":"1445_CR24","doi-asserted-by":"publisher","first-page":"e0184129","DOI":"10.1371\/journal.pone.0184129","volume":"12","author":"L Chen","year":"2017","unstructured":"Chen L, Zhang Y, Wang S, Zhang Y, Huang T, Cai Y. Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways. PloS one. 2017;12(9):e0184129. https:\/\/doi.org\/10.1371\/journal.pone.0184129.","journal-title":"PloS one"},{"key":"1445_CR25","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.032839","author":"S Bello","year":"2018","unstructured":"Bello S, Shimoyama M, Mitraka E, Laulederkind S, Smith C, Eppig J, et al. Disease ontology: improving and unifying disease annotations across species. Dis Models Mech. 2018. https:\/\/doi.org\/10.1242\/dmm.032839.","journal-title":"Dis Models Mech"},{"key":"1445_CR26","doi-asserted-by":"publisher","first-page":"989459","DOI":"10.3389\/fgene.2022.989459","volume":"13","author":"C Xu","year":"2022","unstructured":"Xu C, Sun D, Wei C, Chang H. Bioinformatic analysis and experimental validation identified DNA methylation-related biomarkers and immune-cell infiltration of atherosclerosis. Front Genet. 2022;13:989459. https:\/\/doi.org\/10.3389\/fgene.2022.989459.","journal-title":"Front Genet"},{"key":"1445_CR27","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/j.wneu.2022.06.138","volume":"166","author":"C Huang","year":"2022","unstructured":"Huang C, Hu D, Li K. Identification of biomarkers in intracranial aneurysm and their immune infiltration characteristics. World Neurosurg. 2022;166:e199\u2013214. https:\/\/doi.org\/10.1016\/j.wneu.2022.06.138.","journal-title":"World Neurosurg"},{"key":"1445_CR28","doi-asserted-by":"publisher","first-page":"623170","DOI":"10.3389\/fonc.2021.623170","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhong L, Zou Z, Liang G, Tang Z, Li K, et al. Clinical and prognostic pan-cancer analysis of N6-methyladenosine regulators in two types of hematological malignancies: a retrospective study based on TCGA and GTEx databases. Front Oncol. 2021;11:623170. https:\/\/doi.org\/10.3389\/fonc.2021.623170.","journal-title":"Front Oncol"},{"key":"1445_CR29","doi-asserted-by":"publisher","first-page":"8870353","DOI":"10.1155\/2021\/8870353","volume":"2021","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Xu Y, Li S. Bibliometrics analysis of diagnostic test accuracy studies of bladder cancer. Dis Markers. 2021;2021:8870353. https:\/\/doi.org\/10.1155\/2021\/8870353.","journal-title":"Dis Markers"},{"key":"1445_CR30","doi-asserted-by":"publisher","first-page":"648917","DOI":"10.3389\/fimmu.2021.648917","volume":"12","author":"R Tang","year":"2021","unstructured":"Tang R, Liu X, Liang C, Hua J, Xu J, Wang W, et al. Deciphering the prognostic implications of the components and signatures in the immune microenvironment of pancreatic ductal adenocarcinoma. Front Immunol. 2021;12:648917. https:\/\/doi.org\/10.3389\/fimmu.2021.648917.","journal-title":"Front Immunol"},{"key":"1445_CR31","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson S, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38:W214\u201320. https:\/\/doi.org\/10.1093\/nar\/gkq537.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1445_CR32","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1186\/s12885-019-5951-3","volume":"19","author":"H Wang","year":"2019","unstructured":"Wang H, Tan Z, Hu H, Liu H, Wu T, Zheng C, et al. microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1. BMC Cancer. 2019;19(1):738. https:\/\/doi.org\/10.1186\/s12885-019-5951-3.","journal-title":"BMC Cancer"},{"key":"1445_CR33","doi-asserted-by":"publisher","first-page":"102411","DOI":"10.1016\/j.redox.2022.102411","volume":"55","author":"R Zhou","year":"2022","unstructured":"Zhou R, Chen Y, Li S, Wei X, Hu W, Tang S, et al. TRPM7 channel inhibition attenuates rheumatoid arthritis articular chondrocyte ferroptosis by suppression of the PKC\u03b1-NOX4 axis. Redox Biol. 2022;55:102411. https:\/\/doi.org\/10.1016\/j.redox.2022.102411.","journal-title":"Redox Biol"},{"issue":"1","key":"1445_CR34","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1080\/21655979.2021.1930335","volume":"12","author":"C Zhu","year":"2021","unstructured":"Zhu C, Zhang C, Cui X, Wu J, Cui Z, Shen X. Trichosanthin inhibits cervical cancer by regulating oxidative stress-induced apoptosis. Bioengineered. 2021;12(1):2779\u201390. https:\/\/doi.org\/10.1080\/21655979.2021.1930335.","journal-title":"Bioengineered"},{"key":"1445_CR35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jprot.2018.11.023","volume":"194","author":"C Huang","year":"2019","unstructured":"Huang C, Yang X, Zeng B, Zeng L, Gong X, Zhou C, et al. Proteomic analysis of olfactory bulb suggests CACNA1E as a promoter of CREB signaling in microbiota-induced depression. J Proteom. 2019;194:132\u201347. https:\/\/doi.org\/10.1016\/j.jprot.2018.11.023.","journal-title":"J Proteom"},{"key":"1445_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020299","author":"Y Jiao","year":"2022","unstructured":"Jiao Y, Li Y, Zhang J, Zhang S, Zha Y, Wang J. RRM2 alleviates doxorubicin-induced cardiotoxicity through the AKT\/mTOR signaling pathway. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12020299.","journal-title":"Biomolecules"},{"key":"1445_CR37","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/s0720-048x(98)00038-2","volume":"1998","author":"W Grassi","year":"1998","unstructured":"Grassi W, De Angelis R, Lamanna G, Cervini C. The clinical features of rheumatoid arthritis. Eur J Radiol. 1998;1998:S18-24. https:\/\/doi.org\/10.1016\/s0720-048x(98)00038-2.","journal-title":"Eur J Radiol"},{"issue":"2","key":"1445_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.autrev.2011.09.001","volume":"11","author":"M Prete","year":"2011","unstructured":"Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F. Extra-articular manifestations of rheumatoid arthritis: an update. Autoimmun Rev. 2011;11(2):123\u201331. https:\/\/doi.org\/10.1016\/j.autrev.2011.09.001.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"1445_CR39","first-page":"286","volume":"5","author":"M Cojocaru","year":"2010","unstructured":"Cojocaru M, Cojocaru I, Silosi I, Vrabie C, Tanasescu R. Extra-articular manifestations in rheumatoid arthritis. Maedica. 2010;5(4):286\u201391.","journal-title":"Maedica"},{"key":"1445_CR40","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1146\/annurev.biochem.75.103004.142443","volume":"75","author":"P Nordlund","year":"2006","unstructured":"Nordlund P, Reichard P. Ribonucleotide reductases. Annu Rev Biochem. 2006;75:681\u2013706. https:\/\/doi.org\/10.1146\/annurev.biochem.75.103004.142443.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"1445_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-2958.2006.05493.x","volume":"63","author":"J Herrick","year":"2007","unstructured":"Herrick J, Sclavi B. Ribonucleotide reductase and the regulation of DNA replication: an old story and an ancient heritage. Mol Microbiol. 2007;63(1):22\u201334. https:\/\/doi.org\/10.1111\/j.1365-2958.2006.05493.x.","journal-title":"Mol Microbiol"},{"issue":"2","key":"1445_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/2211738508666200128120142","volume":"8","author":"A Sharma","year":"2020","unstructured":"Sharma A, Kumar P, Ambasta R. Cancer fighting SiRNA-RRM2 loaded nanorobots. Pharm Nanotechnol. 2020;8(2):79\u201390. https:\/\/doi.org\/10.2174\/2211738508666200128120142.","journal-title":"Pharm Nanotechnol"},{"issue":"18","key":"1445_CR43","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1111\/j.1742-4658.2008.06581.x","volume":"275","author":"S Kobayashi","year":"2008","unstructured":"Kobayashi S, Momohara S, Kamatani N, Okamoto H. Molecular aspects of rheumatoid arthritis: role of environmental factors. FEBS J. 2008;275(18):4456\u201362. https:\/\/doi.org\/10.1111\/j.1742-4658.2008.06581.x.","journal-title":"FEBS J"},{"issue":"2","key":"1445_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/s1521-6942(02)00107-9","volume":"17","author":"G Cunnane","year":"2003","unstructured":"Cunnane G, Doran M, Bresnihan B. Infections and biological therapy in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2003;17(2):345\u201363. https:\/\/doi.org\/10.1016\/s1521-6942(02)00107-9.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"1445_CR45","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/rheumatology\/kev421","volume":"55","author":"B Cuppen","year":"2016","unstructured":"Cuppen B, Welsing P, Sprengers J, Bijlsma J, Marijnissen A, van Laar J, et al. Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability. Rheumatology (Oxford). 2016;55(5):826\u201339. https:\/\/doi.org\/10.1093\/rheumatology\/kev421.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1445_CR46","doi-asserted-by":"publisher","first-page":"445","DOI":"10.55563\/clinexprheumatol\/j1l5l3","volume":"39","author":"D Testa","year":"2021","unstructured":"Testa D, Calvacchi S, Petrelli F, Giannini D, Bilia S, Alunno A, et al. One year in review 2021: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2021;39(3):445\u201352.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"1445_CR47","doi-asserted-by":"publisher","first-page":"e0175109","DOI":"10.1371\/journal.pone.0175109","volume":"12","author":"S Snelling","year":"2017","unstructured":"Snelling S, Bas S, Puskas G, Dakin S, Suva D, Finckh A, et al. Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype. PloS one. 2017;12(4):e0175109. https:\/\/doi.org\/10.1371\/journal.pone.0175109.","journal-title":"PloS one"},{"issue":"16","key":"1445_CR48","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJMoa2008250","volume":"383","author":"A Rubbert-Roth","year":"2020","unstructured":"Rubbert-Roth A, Enejosa J, Pangan A, Haraoui B, Rischmueller M, Khan N, et al. Trial of upadacitinib or abatacept in rheumatoid arthritis. N Engl J Med. 2020;383(16):1511\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2008250.","journal-title":"N Engl J Med"},{"issue":"6","key":"1445_CR49","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2217\/imt-2017-0155","volume":"10","author":"S Zhao","year":"2018","unstructured":"Zhao S, Mysler E, Moots R. Etanercept for the treatment of rheumatoid arthritis. Immunotherapy. 2018;10(6):433\u201345. https:\/\/doi.org\/10.2217\/imt-2017-0155.","journal-title":"Immunotherapy"},{"issue":"18","key":"1445_CR50","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s40265-017-0835-9","volume":"77","author":"S Dhillon","year":"2017","unstructured":"Dhillon S. Tofacitinib: a review in rheumatoid arthritis. Drugs. 2017;77(18):1987\u20132001. https:\/\/doi.org\/10.1007\/s40265-017-0835-9.","journal-title":"Drugs"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01445-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01445-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01445-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T18:05:43Z","timestamp":1675101943000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01445-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1445"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01445-7","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]},"assertion":[{"value":"5 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical review and approval was not required for this study in accordance with the local legislation and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}